Literature DB >> 28409174

Neurokinin 1 and opioid receptors: relationships and interactions in nervous system.

Jie Xiao1,2, Si Zeng3, Xiangrui Wang1, Hasan Babazada2, Zhanchun Li1, Renyu Liu2, Weifeng Yu1.   

Abstract

Opioid receptors and neurokinin 1 receptor (NK1R) are found highly expressed in the central nervous system. The co-localization of these two kinds of receptors suggests that they might interact with each other in both the transmission and modulation of the pain signal. In this review, we explore the relationships between opioid receptors and NK1R. Substance P (SP) plays a modulatory role in the pain transmission by activating the NK1R. Opioid receptor activation can inhibit SP release. NK1R is found participating in the mechanisms of the side effects of the opioids, including opioid analgesic tolerance, hyperalgesia, anxiety behaviors of morphine reward and opioids related respiratory depression. A series of compounds such as NK1R antagonists and ligands works on both mu/delta opioid receptor (MOR/DOR) and NK1R were synthesized as novel analgesics that enhance the clinical pain management efficacy and reduce the dosage and side effects. The current status of these novel ligands and the limitations are discussed in this review. Although the working mechanisms of these ligands remained unclear, they could be used as research tool for developing novel analgesic drugs in the future.

Entities:  

Keywords:  Central nervous system; Neurokinin 1 receptor; Opioid receptors; Opioids; Substance P

Year:  2016        PMID: 28409174      PMCID: PMC5388438     

Source DB:  PubMed          Journal:  Transl Perioper Pain Med


  71 in total

1.  Spinal substance P release in vivo during the induction of long-term potentiation in dorsal horn neurons.

Authors:  Abdullahi Warsame Afrah; Atle Fiskå; Johannes Gjerstad; Henrik Gustafsson; Arne Tjølsen; Leif Olgart; Carl Olav Stiller; Kjell Hole; Ernst Brodin
Journal:  Pain       Date:  2002-03       Impact factor: 6.961

2.  The NK1 receptor mediates both the hyperalgesia and the resistance to morphine in mice lacking noradrenaline.

Authors:  Luc Jasmin; Duc Tien; David Weinshenker; Richard D Palmiter; Paul G Green; Gabriella Janni; Peter T Ohara
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-22       Impact factor: 11.205

3.  Modulation of Ca2+ channels by G-protein beta gamma subunits.

Authors:  S Herlitze; D E Garcia; K Mackie; B Hille; T Scheuer; W A Catterall
Journal:  Nature       Date:  1996-03-21       Impact factor: 49.962

4.  Substance P microinjected into the periaqueductal gray matter induces antinociception and is released following morphine administration.

Authors:  Annika Rosén; Yu-Xuan Zhang; Irene Lund; Thomas Lundeberg; Long-Chuan Yu
Journal:  Brain Res       Date:  2004-03-19       Impact factor: 3.252

5.  Dissociation of μ- and δ-opioid inhibition of glutamatergic synaptic transmission in superficial dorsal horn.

Authors:  Paul J Wrigley; Hyo-Jin Jeong; Christopher W Vaughan
Journal:  Mol Pain       Date:  2010-10-26       Impact factor: 3.395

6.  Neurokinin 1 receptor antagonism as a possible therapy for alcoholism.

Authors:  David T George; Jodi Gilman; Jacqueline Hersh; Annika Thorsell; David Herion; Christopher Geyer; Xiaomei Peng; William Kielbasa; Robert Rawlings; John E Brandt; Donald R Gehlert; Johannes T Tauscher; Stephen P Hunt; Daniel Hommer; Markus Heilig
Journal:  Science       Date:  2008-02-14       Impact factor: 47.728

7.  Inhibitory Effect of Endomorphin-2 Binding to the μ-Opioid Receptor in the Rat Pre-Bötzinger Complex on the Breathing Activity.

Authors:  Jian Qi; Hui Li; Ting-Bao Zhao; Ya-Cheng Lu; Ting Zhang; Jin-Lian Li; Yu-Lin Dong; Yun-Qing Li
Journal:  Mol Neurobiol       Date:  2016-01-07       Impact factor: 5.590

Review 8.  Assessment of pain.

Authors:  H Breivik; P C Borchgrevink; S M Allen; L A Rosseland; L Romundstad; E K Breivik Hals; G Kvarstein; A Stubhaug
Journal:  Br J Anaesth       Date:  2008-05-16       Impact factor: 9.166

9.  Caring for patients with chronic pain: pearls and pitfalls.

Authors:  David J Debono; Laura J Hoeksema; Raymond D Hobbs
Journal:  J Am Osteopath Assoc       Date:  2013-08

10.  Neurokinin 1 receptors regulate morphine-induced endocytosis and desensitization of mu-opioid receptors in CNS neurons.

Authors:  Y Joy Yu; Seksiri Arttamangkul; Christopher J Evans; John T Williams; Mark von Zastrow
Journal:  J Neurosci       Date:  2009-01-07       Impact factor: 6.167

View more
  5 in total

Review 1.  Neurokinin receptors in drug and alcohol addiction.

Authors:  Jesse R Schank
Journal:  Brain Res       Date:  2020-02-15       Impact factor: 3.252

2.  Synthesis and Pharmacological Evaluation of Hybrids Targeting Opioid and Neurokinin Receptors.

Authors:  Karol Wtorek; Anna Adamska-Bartłomiejczyk; Justyna Piekielna-Ciesielska; Federica Ferrari; Chiara Ruzza; Alicja Kluczyk; Joanna Piasecka-Zelga; Girolamo Calo'; Anna Janecka
Journal:  Molecules       Date:  2019-12-05       Impact factor: 4.411

Review 3.  Advances in Understanding the Initial Steps of Pruritoceptive Itch: How the Itch Hits the Switch.

Authors:  Shirin Kahremany; Lukas Hofmann; Arie Gruzman; Guy Cohen
Journal:  Int J Mol Sci       Date:  2020-07-10       Impact factor: 5.923

Review 4.  Fentanyl Structure as a Scaffold for Opioid/Non-Opioid Multitarget Analgesics.

Authors:  Piotr F J Lipiński; Joanna Matalińska
Journal:  Int J Mol Sci       Date:  2022-03-02       Impact factor: 5.923

5.  In Vivo, In Vitro and In Silico Studies of the Hybrid Compound AA3266, an Opioid Agonist/NK1R Antagonist with Selective Cytotoxicity.

Authors:  Joanna Matalińska; Piotr F J Lipiński; Piotr Kosson; Katarzyna Kosińska; Aleksandra Misicka
Journal:  Int J Mol Sci       Date:  2020-10-19       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.